BioSpace News Archive

Pictured: Sign of U.S. Department of Health & Huma

Government

HHS Leaves Door Open to Future Medicare Coverage of Obesity Drugs

Last week, The Trump administration reversed a Biden-era proposal for Medicare coverage of anti-obesity treatments. But on Monday, HHS suggested it is open to future policy considerations toward this end.

April 8, 2025

·

2 min read

·

Tristan Manalac

The factor that changes everything. A critical break. A sudden change in plans. A threat and a danger. Recover from the blow and get back on course. Severe stress. Withstand the blow.

Rare diseases

Rallybio Pivots as Antibody for Rare Bleeding Disorder Flunks Dosing Trial

The company is dropping its former lead molecule in favor of another antibody, RLYB116, which is being developed for a variety of rare autoimmune disorders.

April 8, 2025

·

1 min read

·

Dan Samorodnitsky

Human heart. Inner organs disease treatment. Modern design concept with tiny doctor character, medical drugs, equipment, analysis. Vector Illustration

Gene therapy

Lexeo Plots Pivotal Path for Friedreich’s Ataxia Gene Therapy After ‘Compelling’ Phase I/II Data

Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia cardiomyopathy.

April 8, 2025

·

2 min read

·

Tristan Manalac

Funding

Merida Enters Autoimmune and Allergy Arena With $121M Series A

Merida is working on a selective therapy for Graves’ disease, leveraging targeted therapies that can deplete disease-causing autoantibodies.

April 8, 2025

·

2 min read

·

Tristan Manalac

Contemporary art collage of a hand holding an umbrella over a bag of money. The concept of protection of profit and wealth. Copy space.

Tariffs

Trump’s Tariffs Could Challenge Pharma’s Recession-Resistant Reputation

Long considered resistant to economic downturns, the pharmaceutical industry may face a greater challenge this time around as GLP-1s dominate and the population grows older.

April 8, 2025

·

5 min read

·

Annalee Armstrong

Press Releases

BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025

April 8, 2025

·

4 min read

Press Releases

EvolveImmune Therapeutics Announces Translational Research Collaboration to Evaluate Expression of Novel Tumor Target in Muscle-Invasive Bladder Cancer